Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kolchinsky Peter
Relationship:   Director, 10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   21    
Direct Shares   6,648,738    

Indirect Shares

  89,615,900      
Direct Value   $30,628,641    

Indirect Value

  $938,473,759      
Total Shares   96,264,638      
Total Value   $969,102,400      


Achillion Pharmaceuticals Inc
 $29,670,022 Sangamo Biosciences Inc
 $958,619 Forma Therapeutics Holdings, Inc.,
 $0 Achillion Pharmaceuticals Inc
 $29,670,022 Sangamo Biosciences Inc
 $958,619 Forma Therapeutics Holdings, Inc.,
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    0    

     Stock price went up :

    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   14.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aradigm Corp ARDM 10% Owner 2007-03-01 0 2008-01-15 7,681,410    Premium*  
            Curis Inc CRIS 10% Owner 2008-04-15 0 2008-04-15 6,250,564    Premium*  
            Sequenom Inc SQNM 10% Owner 0 2008-06-06 4,617,766    Premium*  
            Biospecifics Technologies Corp BSTC 10% Owner 2008-12-29 0 2009-04-14 825,844    Premium*  
            Lipid Sciences Inc LIPD 10% Owner 2008-03-27 0 2008-03-27 3,705,312    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 2013-09-30 4,816,562 2014-09-11 13,000,000    Premium*  
            Sangamo Biosciences Inc SGMO Former 10% Owner 2014-08-01 1,829,426 2013-07-17 0    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-07 0 2015-10-21 2,314,942    Premium*  
            Ra Pharmaceuticals, Inc. RARX Director, 10% Owner 2016-10-31 0 2020-04-02 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director, 10% Owner 2016-11-21 0 2017-10-12 1,441,070    Premium*  
            G1 Therapeutics Inc GTHX Fmr 10% Owner See Foot... 2017-05-22 0 2017-05-22 2,684,244    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director, 10% Owner 2017-07-25 0 2020-03-13 10,874,613    Premium*  
            Wave Life Sciences Ltd. WVE Director, 10% Owner 2017-11-13 0 2019-01-24 7,775,207    Premium*  
            Dicerna Pharmaceuticals Inc DRNA Director 2017-12-18 0 2019-12-02 0    Premium*  
            Eidos Therapeutics, Inc. EIDX 10% Owner 2018-06-22 0 2018-06-22 2,162,671    Premium*  
            Arvinas Holding Company, Llc ARVN Former 10% Owner 2018-10-01 0 2018-10-01 3,138,412    Premium*  
            Synthorx, Inc. THOR Director, 10% Owner 2018-12-11 0 2020-01-23 0    Premium*  
            Satsuma Pharmaceuticals, Inc. STSA Former 10% Owner 2019-09-17 0 2023-06-08 0    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 0 2019-10-16 5,422,312    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX Director, 10% Owner 2021-06-17 2,750 2021-06-17 9,011,651    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 0 2020-12-10 8,709,882    Premium*  
* Premium Members only  

Records found :    207         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-05-12 4 S $13.01 $386,330 D/D (29,659) 4,745,013 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-07-25 4 S $7.15 $398,089 D/D (55,421) 5,287,794 0 -
ARDM Aradigm Corp 10% Owner   –       –       •   2007-09-11 4 B $1.40 $420,000 I/I 300,000 6,744,010 1.5 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-05-07 4 B $12.09 $431,870 D/D 35,736 4,857,972 2.44 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-03-19 4 S $24.28 $432,432 D/D (17,808) 3,683,000 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-07-22 4 B $7.16 $455,837 D/D 63,283 5,340,990 2.45 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-07-17 4 B $12.26 $456,211 D/D 37,215 2,199,753 2.44 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-08-09 4 B $6.30 $485,100 D/D 77,000 5,314,106 2.45 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2013-07-17 4 S $10.21 $493,401 D/D (48,270) 3,626,503 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-08-27 4 B $6.49 $499,345 D/D 77,000 4,983,117 2.45 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-07 4 B $15.42 $519,310 D/D 33,667 4,475,024 2.44 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-01-03 4 D $9.25 $546,870 I/I (59,100) 4,838,413 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-01-18 4 D $9.23 $550,858 I/I (59,700) 4,462,313 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-05-07 4 B $11.71 $557,989 D/D 47,564 4,822,236 2.44 -
WVE Wave Life Sciences Ltd. Director   –       •       •   2017-11-14 4 B $24.00 $561,550 I/I 23,398 7,512,049 2.25 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-09-17 4 S $7.42 $575,994 D/D (77,600) 4,959,418 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-04-17 4 B $14.02 $581,959 D/D 41,500 4,762,078 2.44 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-07-25 4 S $12.31 $583,951 D/D (47,429) 2,028,274 0 -
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-14 4 B $14.06 $601,792 I/I 42,813 2,279,943 1.5 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-03-23 4 D $11.05 $611,126 I/I (55,300) 3,933,489 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-02-27 4 S $19.26 $623,499 D/D (32,196) 3,725,000 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-02-07 4 S $18.52 $642,432 D/D (34,688) 3,683,002 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-01-02 4 D $9.47 $643,654 I/I (68,000) 4,897,513 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-02-20 4 S $18.39 $649,869 D/D (35,319) 3,683,002 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-05-23 4 S $13.27 $684,713 D/D (51,597) 4,580,960 0 -

  207  Records found
  1   2   3   4  5   6   7   8   9      
  Page 4 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed